Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Manage alerts
Active alerts for Sai Life Sciences
Add new alert
SAILIFE •
NSE
Sai Life Sciences
₹953.05
-55.80 (5.53%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
Business Standard •
5 days ago
Indian CDMOs, including SAI Life Sciences and Akums Drugs, expand capacity as demand for complex drug development rises. Global pharma firms increasingly outsource complex drug work, driving tech investments in Indian CDMOs.
MarketScreener India •
2 weeks ago
Sai Life Sciences reported Q3 FY26 revenue of INR 5.6bn, up 27% y/y, driven by 31% CDMO and 19% CRO growth. Stock surged 44.4% in 12 months; consensus targets imply up to 32.3% upside from current price, trading at P/E of 49.9x FY27.
ScoutQuest •
2 weeks ago
ICRA assigned Sai Life Sciences long-term rating of ICRA AA (Stable). The company received ICRA A1 for short-term rating, totaling Rs. 768.6 crore.
ScoutQuest •
4 weeks ago
Sai Life Sciences shared Q3 9M FY26 earnings call transcript from 6 Feb 2026. Transcript details unaudited financial results for quarter ending 31 Dec 2025.
ScoutQuest •
1 month ago
HDFC Securities released an IPO Note on Sai Life Science. Sai Life Science's CMP was 894.7 as of 09 Feb 26, 16:00.
ScoutQuest •
1 month ago
Sai Life Sciences' Q3 PAT nearly doubles YoY, boosting stock performance. Growth outlook strong with focus on capex and peptide expansion.
BSE •
1 month ago
Sai Life Sciences' Board approved unaudited financial results for Q3 and nine months ending Dec 31, 2025. Revenue from operations stood at Rs. 5,491.8M, with profit after tax at Rs. 976.3M for Q3 FY25.
Livesquawk •
1 month ago
Sai Life Sciences partners with Mabtech to enhance immunology research via advanced assay services. The firm opened a Boston lab as the US hub for its Eyra platform.
Business Standard •
2 months ago
HDFC Securities initiates coverage on Divi's Labs, Sai Life, Piramal Pharma, Anthem Bio, and Laurus Labs. India's CRDMO market is poised to outpace APAC, with strong long-term growth in pharma sector.
Marketsmojo •
2 months ago
Sai Life Sciences hit an all-time high of Rs.972.65 on 6 Jan 2026. The milestone reflects strong performance in the Pharmaceuticals sector.